Skip to content

XOMA Corporation XOMA Intangible Purchases

Intangible Purchases at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$0-100%
Zymeworks logo
ZymeworksZYME
$0-100%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$5M-66.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0-100%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.49M+128%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: XOMA Corporation’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's intangible purchases?
XOMA Corporation (XOMA) reported intangible purchases of $111K in Q3 2025.
How has XOMA Corporation's intangible purchases changed year-over-year?
XOMA Corporation's intangible purchases decreased by 97.8% year-over-year, from $5.04M to $111K.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.